Axxcess Wealth Management LLC increased its stake in Relx Plc (NYSE:RELX – Free Report) by 6.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 5,633 shares of the technology company’s stock after buying an additional 363 shares during the quarter. Axxcess Wealth Management LLC’s holdings in Relx were worth $256,000 as of its most recent SEC filing.
Other institutional investors also recently bought and sold shares of the company. CENTRAL TRUST Co lifted its position in Relx by 1,290.2% in the fourth quarter. CENTRAL TRUST Co now owns 570 shares of the technology company’s stock worth $26,000 after buying an additional 529 shares during the last quarter. Versant Capital Management Inc bought a new stake in shares of Relx during the fourth quarter worth $31,000. Sierra Ocean LLC bought a new stake in shares of Relx during the fourth quarter worth $43,000. Private Trust Co. NA lifted its position in shares of Relx by 119.9% during the third quarter. Private Trust Co. NA now owns 1,038 shares of the technology company’s stock worth $49,000 after purchasing an additional 566 shares during the last quarter. Finally, Whipplewood Advisors LLC bought a new stake in shares of Relx during the fourth quarter worth $74,000. 15.02% of the stock is currently owned by institutional investors.
Relx Stock Performance
RELX stock opened at $49.96 on Friday. The company has a debt-to-equity ratio of 1.46, a current ratio of 0.52 and a quick ratio of 0.47. The business has a 50-day moving average price of $49.18 and a 200 day moving average price of $47.70. The company has a market capitalization of $92.72 billion, a P/E ratio of 26.86, a PEG ratio of 2.73 and a beta of 0.90. Relx Plc has a 1-year low of $40.25 and a 1-year high of $51.99.
Relx Increases Dividend
Wall Street Analysts Forecast Growth
RELX has been the subject of several research analyst reports. StockNews.com downgraded Relx from a “buy” rating to a “hold” rating in a research report on Tuesday, March 4th. Redburn Atlantic initiated coverage on Relx in a research report on Wednesday, January 8th. They set a “buy” rating for the company. Finally, Barclays upgraded Relx from an “equal weight” rating to an “overweight” rating in a research report on Friday, March 14th.
Read Our Latest Report on RELX
Relx Profile
RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.
Recommended Stories
- Five stocks we like better than Relx
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Alphabet Stock Becomes a Low-Risk, High-Reward Play
- What Are Dividend Achievers? An Introduction
- Affirm Stock: Should You Buy the Dip After Walmart Setback?
Want to see what other hedge funds are holding RELX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Relx Plc (NYSE:RELX – Free Report).
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.